111 related articles for article (PubMed ID: 23806684)
1. LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells.
Dai Y; Mercanti F; Dai D; Wang X; Ding Z; Pothineni NV; Mehta JL
Biochem Biophys Res Commun; 2013 Jul; 437(1):62-6. PubMed ID: 23806684
[TBL] [Abstract][Full Text] [Related]
2. Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.
Sun Y; Chen X
Fundam Clin Pharmacol; 2011 Oct; 25(5):572-9. PubMed ID: 21077940
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
[TBL] [Abstract][Full Text] [Related]
4. Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation.
Ying W; Meiyan S; Wen C; Kaizu X; Meifang W; Liming L
Redox Rep; 2023 Dec; 28(1):2218684. PubMed ID: 37278349
[TBL] [Abstract][Full Text] [Related]
5. Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g.
Ding Z; Wang X; Schnackenberg L; Khaidakov M; Liu S; Singla S; Dai Y; Mehta JL
Int J Cardiol; 2013 Sep; 168(2):1378-85. PubMed ID: 23305858
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between LOX-1 and PCSK9 in vascular tissues.
Ding Z; Liu S; Wang X; Deng X; Fan Y; Shahanawaz J; Shmookler Reis RJ; Varughese KI; Sawamura T; Mehta JL
Cardiovasc Res; 2015 Sep; 107(4):556-67. PubMed ID: 26092101
[TBL] [Abstract][Full Text] [Related]
7. The pharmacologic basis for clinical differences among GLP-1 receptor agonists and DPP-4 inhibitors.
Morales J
Postgrad Med; 2011 Nov; 123(6):189-201. PubMed ID: 22104467
[TBL] [Abstract][Full Text] [Related]
8. Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.
Dai Y; Cao Y; Zhang Z; Vallurupalli S; Mehta JL
Cardiovasc Drugs Ther; 2017 Feb; 31(1):19-27. PubMed ID: 28084571
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta.
Ding Z; Liu S; Wang X; Deng X; Fan Y; Sun C; Wang Y; Mehta JL
Antioxid Redox Signal; 2015 Mar; 22(9):760-71. PubMed ID: 25490141
[TBL] [Abstract][Full Text] [Related]
10. DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway.
Dai Y; Dai D; Wang X; Ding Z; Mehta JL
Cardiovasc Drugs Ther; 2014 Oct; 28(5):425-32. PubMed ID: 25022544
[TBL] [Abstract][Full Text] [Related]
11. Regulation of MSR-1 and CD36 in macrophages by LOX-1 mediated through PPAR-γ.
Dai Y; Su W; Ding Z; Wang X; Mercanti F; Chen M; Raina S; Mehta JL
Biochem Biophys Res Commun; 2013 Feb; 431(3):496-500. PubMed ID: 23333385
[TBL] [Abstract][Full Text] [Related]
12. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species.
Chen XP; Xun KL; Wu Q; Zhang TT; Shi JS; Du GH
Vascul Pharmacol; 2007 Jul; 47(1):1-9. PubMed ID: 17433786
[TBL] [Abstract][Full Text] [Related]
13. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
[TBL] [Abstract][Full Text] [Related]
14. Degradation of heparan sulfate proteoglycans enhances oxidized-LDL-mediated autophagy and apoptosis in human endothelial cells.
Ding Z; Wang X; Khaidakov M; Liu S; Dai Y; Mehta JL
Biochem Biophys Res Commun; 2012 Sep; 426(1):106-11. PubMed ID: 22910414
[TBL] [Abstract][Full Text] [Related]
15. Role of LOX-1 and ROS in oxidized low-density lipoprotein induced epithelial-mesenchymal transition of NRK52E.
Wang R; Ding G; Liang W; Chen C; Yang H
Lipids Health Dis; 2010 Oct; 9():120. PubMed ID: 20958994
[TBL] [Abstract][Full Text] [Related]
16. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells.
Chen J; Mehta JL; Haider N; Zhang X; Narula J; Li D
Circ Res; 2004 Feb; 94(3):370-6. PubMed ID: 14684629
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
Ban K; Noyan-Ashraf MH; Hoefer J; Bolz SS; Drucker DJ; Husain M
Circulation; 2008 May; 117(18):2340-50. PubMed ID: 18427132
[TBL] [Abstract][Full Text] [Related]
18. Modulation of oxidized-LDL receptor-1 (LOX1) contributes to the antiatherosclerosis effect of oleanolic acid.
Jiang Q; Wang D; Han Y; Han Z; Zhong W; Wang C
Int J Biochem Cell Biol; 2015 Dec; 69():142-52. PubMed ID: 26510581
[TBL] [Abstract][Full Text] [Related]
19. [Tyrosine kinase dependent lectin-like oxidized LDL receptor-1 upregulation by thrombin and factor Xa in vascular smooth muscle cells].
Su L; Miao YD; Sun LX; Sun NL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):262-6. PubMed ID: 16630467
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level.
Ishibashi Y; Nishino Y; Matsui T; Takeuchi M; Yamagishi S
Metabolism; 2011 Sep; 60(9):1271-7. PubMed ID: 21388644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
